Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/26/2008

20 - $40 million

Add estimated non-cash stock compensation $27.0 million

Non-GAAP estimated net income for 2008 $47 - $67 million

Management believes that this non-GAAP information is useful to investors, taken in conjunction with BioMarin's GAAP net income guidance for 2008 because Management uses such information internally for its operating, budgeting and financial planning purposes, and to enhance investors' overall understanding of the company's prospects for the future.

Anticipated Upcoming Milestones

-- 1Q08/early 2Q08: Initiation of PEG-PAL Phase I patient study with

plans to roll into a Phase 2 study in 3Q08

-- 4Q08: Results from Phase 2 Sickle Cell Disease trial

-- 4Q08: Results from Phase 2 PAD trial

Upcoming Investor Conferences and Events

-- March 17-19: Citi Small/Mid Cap Conference -- Las Vegas

-- March 17-20: Cowen Healthcare Conference -- Boston

-- March 18-20: Lehman Brothers Global Healthcare Conference -- Miami

-- June 5: BioMarin R&D Day -- New York City

BioMarin will host a conference call and webcast to discuss fourth quarter and full year 2007 financial results today, Tuesday, February 26, at 5:00 p.m. ET (22:00 CET). This event can be accessed on the investor section of the BioMarin website at http://www.BMRN.com.

Date: February 26, 2008

Time: 5:00 p.m. ET (22:00 CET)

U.S. / Canada Dial-in Number: 866.713.8564

International Dial-in Number: 617.597.5312

Participant Code: 79434433

Replay Dial-in Number: 888.286.8010

Replay International Dial-in Number: 617.801.6888

Replay Code: 87203261

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-cl
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. BioMarin to Present at the BioCentury NewsMakers Conference
3. BioMarin to Present at the Rodman & Renshaw 9th Annual Healthcare Conference
4. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
5. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
6. BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
7. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... PA (PRWEB) June 18, 2013 Demanding ... Ball Lenses engineered of synthetic Sapphire and Glass Ball ... sizes from Swiss Jewel Company , of Philadelphia ... by expanding and collimating the light beams without the ... optical clarity and natural durability (9 mohs) make it ...
(Date:6/18/2013)... , June 18, 2013 ... the release of the HELM biomolecular representation standard ... source MIT licence. HELM (Hierarchical Editing ... wide range of biomolecules (e.g. proteins, nucleotides, antibody ... small-molecule and sequence-based informatics methodologies impractical or unusable. ...
(Date:6/18/2013)... , June 18, 2013 Mapi ... (APIs), generic and innovative intermediates, and finished dosage forms based ... has been granted a United States ... Europe for the oral treatment of ... is titled Intermediate Compounds and Processes for the Preparation ...
(Date:6/18/2013)... THE WOODLANDS, Texas , June 18, 2013 ... LXRX ), a biopharmaceutical company focused on ... that John Northcott has joined the ... strategy, and operations. Mr. Northcott brings extensive commercial ... on-market commercialization across a variety of therapeutic areas. ...
Breaking Biology Technology:Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3
... applaud Senator Ted Kanavas for his desire to align best ... to see the senator refer to the Sarbanes-Oxley Act of ... at this concept a little closer. President Bush signed Sarbox ... corporate accounting scandals, most notably Enron and WorldCom. , ,Sarbox ...
... in the field and navigating at the helm of several ... (which is located in Woodridge, Ill. across from Argonne ... advance his drug discovery company. , ,Following a six-month ... the next few weeks with financial adviser Legg Mason ...
... with Congresswomen Tammy Baldwin at her Madison office about ... for technology development, as well as how we can ... best known for her unwavering commitment to farmers, senior ... is emerging as a leader in the Wisconsin technology ...
Cached Biology Technology:My View - State Government Needs Integrity To Build Investor Confidence 2Advanced Life Sciences to Hit the Road For $30 Million in Funding 2Advanced Life Sciences to Hit the Road For $30 Million in Funding 3Advanced Life Sciences to Hit the Road For $30 Million in Funding 4WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 2WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 3WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 4WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 5WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 6
(Date:6/17/2013)... BOSTON , June 17, 2013 ... prolific, the need to secure them grows exponentially, ... the latest report from Heavy Reading Insider ... from Heavy Reading ( www.heavyreading.com ). ... Smartphones examines the market for biometric authentication on ...
(Date:6/17/2013)... The AGA Research Foundation and Horizon Pharma further ... gastroenterology with the 2013 AGA-Horizon Pharma Fellow Abstract Prizes ... "In its third year, this competition continues to grow ... promising careers in basic and clinical research," said Nicholas ... Foundation. "We are extremely proud of all that these ...
(Date:6/17/2013)... French . A ... Alzheimer,s disease can be reversed with treatment. The study by ... Neuro, at McGill University and at Universit de Montral found ... brain of mice with advanced Alzheimer,s disease (AD) recovers memory ... of Neuroinflammation in May, also suggest an underlying mechanism ...
Breaking Biology News(10 mins):Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3Horizon Pharma Abstract Prizes recognize promising fellows and students 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2
... cancer drug asparaginase fails to help cure some children ... certain cells in the bone marrow counteract the effect ... Children's Research Hospital. , The researchers showed that ... niche for leukemic cells by releasing large amounts of ...
... Using a biochemical version of a computer chip, a team ... related to the mating habits of yeast cells. ... Publication of the journal Nature, shed new light on the ... from the environment through a process called signal transduction. That ...
... Harvard School of Public Health (HSPH) finds that polio vaccination ... of over $180 billion, even without including the large, intangible ... to retrospectively demonstrate the enormous benefits of polio vaccination appears ... December 2006 issue of Risk Analysis. , The history of ...
Cached Biology News:Leukemic cells find safe haven in bone marrow 2Leukemic cells find safe haven in bone marrow 3Microfluidic chip helps solve cellular mating puzzle 2Microfluidic chip helps solve cellular mating puzzle 3Billions of dollars saved in US by polio vaccination 2
Reacts with the 80 kDa fragment of the M-chain of human merosin....
Goat polyclonal to Rabenosyn 5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: ELKHTLAKQKGGTD, corresponding to C terminal amino acids 771-784 of Human Rabenosyn 5. Entr...
Acetyl CoA Carboxylase Antibody...
Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...
Biology Products: